Senior insider sale
Chief Legal Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$1.06M
27.06K shares
What this filing means
SULLIVAN MARK plans to sell 27.06K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $1.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2026ACC: 0001950047-26-009823
Officer· Chief Legal Officer
Since Feb 2026
27.06K
Shares to sell
$1.06M
Approx. market value
14.05K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Services Rendered
9/25/2026
14.05KTotal acquired14.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2026 | Restricted Stock Vesting Under a Registered Plan Services Rendered | 14.05K | — |
| Total | 14.05K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
13.01K
Market value
$548.0K
6/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.05K
Market value
$516.1K
9/25/2026
Total
Units
27.06K
Value
$1.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 13.01K | $548.0K | — | Completed |
| Planned — Approximate Date | ||||
9/25/2026 | 14.05K | $516.1K | NASDAQ | Planned |
| Total | 27.06K | $1.06M | ||